Home/Pipeline/Engineered Human Myocardium (EHM) Patch

Engineered Human Myocardium (EHM) Patch

Advanced Heart Failure

Phase 1Active

Key Facts

Indication
Advanced Heart Failure
Phase
Phase 1
Status
Active
Company

About Repairon

Repairon is a private, clinical-stage biotech based in Munich, Germany, developing iPSC-derived engineered heart muscle (EHM) patches for the treatment of advanced heart failure. The company has advanced its lead program into a first-in-human clinical trial (BioVAT-HF) and has established GMP manufacturing for its investigational products. With a strong IP position in tissue engineering and a leadership team combining deep scientific expertise with successful biotech commercialization experience, Repairon is positioned at a key value inflection point as it generates initial clinical data for its novel regenerative therapy.

View full company profile

Other Advanced Heart Failure Drugs

DrugCompanyPhase
ICOMS Flowmaker®FineHeartFirst-In-Human (FIH)